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Caenorhabditis elegans inhibitor of apoptosis protein (IAP)
homologue BIR-1 plays a conserved role in cytokinesis
Abstract
BACKGROUND: Inhibitor of apoptosis proteins (IAPs) suppress apoptotic cell death in several model
systems and are highly conserved between insects and mammals. All IAPs contain at least one copy of
the approximately 70 amino-acid baculovirus IAP repeat (BIR), and this domain is essential for the
anti-apoptotic activity of the IAPs. Both the marked structural diversity of IAPs and the identification of
BIR-containing proteins (BIRPs) in yeast, however, have led to the suggestion that BIRPs might play
roles in other, as yet unidentified, cellular processes besides apoptosis. Survivin, a human BIRP, is
upregulated 40-fold at G2-M phase and binds to mitotic spindles, although its role at the spindle is still
unclear. RESULTS: We have identified and characterised two Caenorhabditis elegans BIRPs,BIR-1 and
BIR-2; these proteins are the only BIRPs in C. elegans. The bir-1 gene is highly expressed during
embryogenesis with detectable expression throughout other stages of development; bir-2 expression is
detectable only in adults and embryos. Overexpression of bir-1 was unable to inhibit developmentally
occurring cell death in C. elegans and inhibition of bir-1 expression did not increase cell death. Instead,
embryos lacking bir-1 were unable to complete cytokinesis and they became multinucleate. This
cytokinesis defect could be partially suppressed by transgenic expression of survivin, the mammalian
BIRP most structurally related to BIR-1, suggesting a conserved role for BIRPs in the regulation of
cytokinesis. CONCLUSIONS: BIR-1, a C. elegans BIRP, is probably not involved in the general
regulation of apoptosis but is required for embryonic cytokinesis. We suggest that BIRPs may regulate
cytoskeletal changes in diverse biological processes including cytokinesis and apoptosis.
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Caenorhabditis elegans inhibitor of apoptosis protein (IAP)
homologue BIR-1 plays a conserved role in cytokinesis
Andrew G. Fraser*†, Claerwen James†‡, Gerard I. Evan‡ and
Michael O. Hengartner*
Background: Inhibitor of apoptosis proteins (IAPs) suppress apoptotic cell
death in several model systems and are highly conserved between insects and
mammals. All IAPs contain at least one copy of the ~70 amino-acid baculovirus
IAP repeat (BIR), and this domain is essential for the anti-apoptotic activity of the
IAPs. Both the marked structural diversity of IAPs and the identification of BIR-
containing proteins (BIRPs) in yeast, however, have led to the suggestion that
BIRPs might play roles in other, as yet unidentified, cellular processes besides
apoptosis. Survivin, a human BIRP, is upregulated 40-fold at G2–M phase and
binds to mitotic spindles, although its role at the spindle is still unclear.
Results: We have identified and characterised two Caenorhabditis elegans
BIRPs, BIR-1 and BIR-2; these proteins are the only BIRPs in C. elegans. The
bir-1 gene is highly expressed during embryogenesis with detectable
expression throughout other stages of development; bir-2 expression is
detectable only in adults and embryos. Overexpression of bir-1 was unable to
inhibit developmentally occurring cell death in C. elegans and inhibition of bir-1
expression did not increase cell death. Instead, embryos lacking bir-1 were
unable to complete cytokinesis and they became multinucleate. This cytokinesis
defect could be partially suppressed by transgenic expression of survivin, the
mammalian BIRP most structurally related to BIR-1, suggesting a conserved
role for BIRPs in the regulation of cytokinesis.
Conclusions: BIR-1, a C. elegans BIRP, is probably not involved in the general
regulation of apoptosis but is required for embryonic cytokinesis. We suggest
that BIRPs may regulate cytoskeletal changes in diverse biological processes
including cytokinesis and apoptosis.
Background
The basal machinery of apoptosis is highly conserved in
metazoa, comprising at least three functional components:
caspases, a family of cysteine proteases whose activity is
required for apoptosis in all metazoans thus far examined
[1]; caspase activators, such as Caenorhabditis elegans CED-4
and mammalian Apaf-1; and the Bcl-2 family of apoptotic
regulators [2]. In addition to these, the anti-apoptotic
inhibitor of apoptosis protein (IAP) family is highly con-
served between insects and mammals and may thus repre-
sent a fourth component of the basal conserved apoptotic
machinery (reviewed in [3]).
IAPs were initially identified as baculovirus proteins that
prevent host cell apoptosis following infection [4,5] and a
number of structurally related cellular homologues have
since been identified [6–10]. These classical IAPs have
either two or three copies of a ~70 amino-acid domain —
the baculovirus IAP repeat (BIR) — at the amino terminus
and a C3HC4 RING finger domain at the carboxyl termi-
nus [5]. BIRs contain an invariant C2HC motif, suggesting
a role in metal ion coordination [4], but these regions
contain no other known motifs [3].
Cellular IAPs have been shown to suppress apoptosis in a
number of model systems. In Drosophila, loss-of-function
mutations in the IAP Diap-1, encoded by the thread locus,
enhance killing by the pro-apoptotic gene reaper [8].
Ectopic expression of Diap-1 suppresses killing by all
three of the Drosophila apoptotic triggers — reaper, hid and
grim — both in vivo [11] and in insect cells in culture
[12,13]. In mammals, overexpression of IAPs [6,7,9,14]
and addition of certain IAPs to cell lysates [15,16] have
been shown to suppress apoptosis induced by a variety of
stimuli, including treatment of cells with drugs and addi-
tion of either active caspases or the caspase activator
cytochrome c to cell lysates.
The suppression of apoptosis in both mammalian and
insect cells by IAPs requires the BIRs of these proteins.
Recently, BIRs have been suggested to suppress apoptosis
by direct and selective inhibition of specific caspases
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[15–18]. But, although the X-linked IAP Xiap, the human
IAPs c-Iap1 and c-Iap2, and the neural inhibitory protein
(NAIP) all display a similar anti-apoptotic activity in mam-
malian cells, their ability to inhibit caspases varies by over
three orders of magnitude. There is therefore a substantial
discrepancy between the ability of an IAP to inhibit apop-
tosis and its ability to inhibit caspases, suggesting that
BIRs may regulate apoptosis via other mechanisms in
addition to the direct inhibition of caspases.
BIRs have more recently been identified in structurally
diverse proteins including NAIP, a gene whose mutation
may contribute to spinal muscular atrophy [19], survivin
[20], which contains a single BIR, and BRUCE, a giant
ubiquitin-conjugating enzyme that contains a BIR [21].
The structural diversity of BIR-containing proteins
(BIRPs) suggests either that BIRs link many diverse path-
ways to the regulation of apoptosis or that BIRs are
involved in a wide range of biological processes in addition
to apoptosis. The identification of BIRPs in both Saccha-
romyces cerevisiae and Schizosaccharomyces pombe [3] — organ-
isms that have no identified apoptotic programme
(reviewed in [22]) — would tend to support the latter view.
Here, we report our characterisation of two BIRPs in
C. elegans, one of which is required for the completion of
cytokinesis. We demonstrate that this is a conserved func-
tion of BIRPs and suggest that BIRPs can regulate
cytoskeletal rearrangements involved in multiple biologi-
cal processes, including both cytokinesis and apoptosis.
Results
The C. elegans genome encodes two BIR-containing proteins
The C. elegans genome sequence consortium has identified
two C. elegans genes encoding proteins with homology to
the BIRs of IAPs (T27F2.3 and C50B8.2) [23] which we
call bir-1 and bir-2. No other proteins containing significant
homology to BIRs were found in C. elegans and there are
unlikely to be more BIRPs in this organism as the sequenc-
ing of the genome is essentially complete. We cloned the
bir-1 and bir-2 cDNAs (see Materials and methods); in both
cases the sequence of the predicted open-reading frames
(ORFs) was identical to that predicted by the C. elegans
genome sequence consortium (Figure 1a). The BIR-1 and
BIR-2 proteins contain one and two BIRs, respectively,
and have no other domains of known homology
(Figure 1b). The BIRs of these proteins are most closely
related to those of survivin and to the S. pombe and S. cere-
visiae BIRs (Figure 1c). BIR-1 is also structurally similar to
survivin: both are approximately 150 amino acids in length
and contain a single amino-terminal BIR.
The bir-1 and bir-2 genes each have a single transcript
(Figure 2). Although bir-1 is highly expressed in embryos,
with a stable lower level of expression throughout all other
developmental stages, bir-2 expression is very low and
detectable only in adults and embryos. The transcript
sizes were the same as those predicted by the sizes of the
cloned cDNAs, confirming that full-length cDNAs had
been isolated for both genes. Both the structural similarity
between BIR-1 and survivin proteins and the greater and
more extensive expression of bir-1 compared with bir-2
led us to concentrate on the characterisation of bir-1.
Overexpression of bir-1 does not affect cell death in vivo
Overexpression of BIRPs has been shown to suppress cell
death in a wide variety of contexts. BIRs are required for
the anti-apoptotic activity of BIRPs and have been shown
to inhibit caspases directly in vitro; inhibition of caspase
activity has therefore been suggested to be the mecha-
nism by which BIRPs exert their anti-apoptotic effects.
The activity of the C. elegans caspase CED-3 is required
for cell death in this nematode [24]. Inhibition of CED-3
activity in vivo, either by genetic mutations in ced-3 itself
[24] or by overexpression of the caspase inhibitor p35 [25],
results in the suppression of developmentally occurring
cell deaths.
To investigate whether, like p35, BIR-1 could suppress
cell death in vivo, we generated transgenic worms in which
sequences encoding BIR-1 amino-terminally tagged with a
haemagglutinin (HA) epitope (HA–BIR-1) were placed
under control of a heatshock-inducible promoter (trans-
genic lines hsHA–BIR-1 a, b, e and f); these lines also
express green fluorescent protein (GFP) under the control
of the same heatshock promoters to allow this protein to
serve as a marker for heatshock-inducible expression.
During normal C. elegans development, 14 specific cells in
the anterior pharynx undergo apoptosis. Perturbation of
the cell death machinery (for example, through mutations
in ced-3 [26], ced-4 [26], ced-9 [27] or egl-1 [28]) alters the
number of deaths and even very weak effects on cell death
(such as 2% additional survival) can be observed.
We induced HA–BIR-1 expression by subjecting
HA–BIR-1-expressing C. elegans lines to heatshock at a
stage before the onset of developmental cell deaths and
counted the number of surviving cells in the anterior
pharynx 48 hours later. To ensure that the experimental
conditions would permit us to observe a suppression of
cell death, a parallel experiment was carried out with ced-9,
the nematode bcl-2 homologue that suppresses cell death
in C. elegans [27,29]. Although induced overexpression of
ced-9 markedly suppressed cell death in the pharynx, no
significant effect was seen following induction of
HA–BIR-1 expression (Figure 3).
To ensure that the HA epitope had not affected any puta-
tive BIR-1 anti-apoptotic activity, we repeated analogous
experiments with transgenic lines expressing either
carboxy-terminally Myc-tagged BIR-1 or untagged BIR-1
under control of the same heatshock promoters; none of
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these lines demonstrated any ability of BIR-1 to suppress
apoptosis following heatshock (data not shown). To ensure
that the heatshock promoters could drive expression in the
cells destined to die, we examined GFP expression in all
transgenic lines tested following heatshock. In all lines
tested, GFP expression was high and almost ubiquitous
Figure 1
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Predicted sequences of BIR-1 and BIR-2 and sequence analysis.
(a) Primary predicted amino-acid sequences of BIR-1 and BIR-2. The
single BIR of BIR-1 and the two BIRs of BIR-2 are underlined;
conserved C2HC residues are shaded in grey. (b) Schematic depiction
of the domain structure of BIR-1, BIR-2, survivin, S. pombe BIRP and
human c-Iap1. BIRs are shown as grey shaded boxes, the RING finger
of c-Iap1 as a black box and the caspase-recruiting domain (CARD) of
c-Iap1 as a white box. The P loop (a predicted ATP-binding motif) of 
S. pombe BIRP is shown as an open circle. (c) Alignment of BIRs of
BIR-1, BIR-2, survivin, S. pombe BIRP and human c-Iap1. BIRs were
aligned using PileUp (gap creation penalty = 12; gap extension
penalty = 4). Residues identical in five or more sequences are shaded
in dark grey; residues conserved in five or more sequences are shaded
in light grey. The conserved C2HC residues are marked with asterisks.
Figure 2
Expression of bir-1 and bir-2 during 
C. elegans development. Northern blots
containing 10 µg total RNA purified from
embryos (E), larval stages 1–4 (L1–L4) or
adult worms (A) were probed with 32P-
labelled DNA probes corresponding to the
ORFs of either bir-1 or bir-2. The positions of
size markers are indicated on the left of each
blot and represent the positions of rRNAs.
Ethidium-bromide-stained gels with large
rRNA levels as loading controls are shown
below the blots.
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(data not shown), mirroring the pattern of heatshock-pro-
moter-induced expression previously described [30].
Our data indicate that overexpression of bir-1 has no effect
on cell death in the pharynx. We conclude that if bir-1
overexpression can affect the execution of cell death in
C. elegans, this effect is negligible in comparison to that of
ced-9 or p35. We performed analogous overexpression
experiments with bir-2 and also failed to detect any effect
on cell death (unpublished observations).
Inhibition of bir-1 does not affect cell death in the
hermaphrodite germ line
The adult hermaphrodite germ line of C. elegans has a con-
tinuously proliferating population of cells that give rise to
oocytes [31]. A low level of cell death occurs in wild-type
germ lines, increasing with the age of the adult animal
[32]. Mutations that suppress somatic cell death (such as
loss-of-function mutations in either ced-3 or ced-4) also sup-
press this germ-cell death, suggesting that germ-cell death
uses the same cell death machinery as all somatic apop-
totic cell deaths. Loss-of-function mutations of ced-9
greatly increase the number of germ-line deaths [32]. If,
like ced-9, bir-1 has a general anti-apoptotic function, then
inhibition of bir-1 in the germ line might be expected to
result in an increase in the number of germ-cell deaths.
We used RNA-mediated interference (RNAi) to inactivate
either bir-1 or ced-9 in the germ line. RNAi is a technique
whereby the injection of double-stranded RNA (dsRNA)
corresponding to sequences in the gene of interest results
in the potent and specific inhibition of gene activity [33].
Animals were injected in a single gonad arm with dsRNA
corresponding to either bir-1 or ced-9 ORFs or with water
alone and the germ line analysed 28 hours later. Whereas
ced-9(RNAi) treatment greatly increased the number of
germ-cell deaths observed, injection of bir-1 dsRNA had
no observable effect on cell death in the germ line
(Figure 4). Similarly, injection of bir-2 dsRNA failed to
affect germ-cell death (unpublished observations). We
conclude that, unlike ced-9, bir-1 has no major role in the
suppression of apoptosis in the germ line.
Inhibition of bir-1 causes a defect in cytokinesis
To determine whether bir-1 is required for any other
aspect of C. elegans development, we again used RNAi to
inactivate bir-1 and then analysed the phenotype of
injected worms and their progeny. We found that ablation
of bir-1 resulted in 100% embryonic lethality. The
embryos were multinucleate (Figure 5a) and over 75% of
embryos failed to form more than two cells. The observed
defects appeared to result from an inability of bir-1(RNAi)
embryos to complete cytokinesis (Figure 5b). Whereas
cytokinesis initiated normally, and the cleavage furrow
progressed to a great extent, cytokinesis failed to complete
and the cleavage furrow subsequently regressed. During
early divisions in a bir-1(RNAi) embryo, both the position
and timing of cytokinesis was almost identical to that seen
in wild-type embryos, suggesting that polarity was unaf-
fected by bir-1 inactivation (Figure 5b). Following the
regression of the cleavage furrow, the nuclei entered a
new cell cycle, resulting in highly multinucleate zygotes.
The bir-1(RNAi) embryos were also defective in the extru-
sion of the polar body, a process which is essentially a
highly asymmetric cytokinesis [34]. During normal germ-
line development, oocytes are arrested at prophase of
meiosis I until fertilisation. Following fertilisation, meiosis I
and II are completed and additional chromosomes are
extruded by cytokinesis to form the polar body. The polar
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Figure 3
Expression of HA–BIR-1 does not suppress
cell death in the pharynx of C. elegans.
(a) Lines expressing either heatshock-
inducible amino-terminally HA-tagged BIR-1
(hsHA–BIR-1) or CED-9 (hsCED-9) were
subjected to heatshock before the onset of
developmental cell death. Embryos were
allowed to hatch and the number of additional
cells in the pharynges of transgenic L3–L4
larvae was quantitated 48 h later. Four
independent heatshock HA–BIR-1 transgenic
lines were analysed (a,b,e,f). In each case,
data shown are the mean number of additional
cells in the anterior pharynx ± standard
deviation. As a comparison, strong loss-of-
function ced-3 worms (n717) have an average
of 12.5 ± 0.4 extra cells [56]. (b) HA–BIR-1 is
efficiently expressed in transgenic lines
following heatshock. The transgenic lines
described in (a) were subjected to heatshock
and lysates made 90 min later. Blots were
probed with rabbit polyclonal anti-HA
antibodies or murine monoclonal anti-tubulin
antibodies (to examine tubulin levels as a
loading control). The hsBIR-1–Myc lysate is
included as a negative control for the anti-HA
antibody probing.
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body was clearly observed in all wild-type embryos (marked
in Figure 5b) and was absent in bir-1(RNAi) embryos.
To ensure that the cytokinesis defect that we observed
was genuinely an effect of bir-1 inhibition and not a non-
specific effect of injection of bir-1 dsRNA, we carried out
several controls. First, we showed that two dsRNA species
corresponding to non-overlapping regions of the bir-1
cDNA (nucleotides 25–310 and 311–605, respectively)
gave an identical phenotype to that obtained following
injection of dsRNA corresponding to the bir-1 ORF (data
not shown), demonstrating that the phenotype was indeed
specific to bir-1. Second, to confirm that bir-1 was indeed
being silenced, we showed that injection of dsRNA corre-
sponding to the bir-1 ORF silenced a transgene expressing
a GFP–BIR-1 fusion protein under the control of a 3 kb
region of the bir-1 promoter, but had no effect on a trans-
gene expressing GFP alone under the control of the same
promoter region (data not shown). Finally, injection of
over a dozen other dsRNA species (including bir-2, which
failed to give any detectable phenotype) did not result in a
similar defect (unpublished observations; Mona Spector,
personal communication). These controls confirmed that
bir-1 RNAi treatment silences only transcripts containing
bir-1 sequences (and does not affect the bir-1 promoter
activity) and that the phenotype observed was genuinely
due to bir-1 inactivation.
Survivin expression partially suppresses the cytokinesis
defect caused by bir-1 inhibition
The mammalian BIRP with the highest degree of structural
and sequence similarity to BIR-1 is survivin [20]. To deter-
mine whether survivin expression could rescue the cytoki-
nesis defect that arose following bir-1 ablation, we carried
out the following experiment. GFP or an amino-terminally
FLAG-tagged survivin ORF were cloned downstream of
approximately 3 kb of the bir-1 5′ region into a vector to
give constructs pbir-1GFP and pbir-1Svn, respectively. In
this way, survivin could be expressed transgenically in vivo
under the control of bir-1 5′ regulatory elements, and GFP
could be used as a co-injection marker to identify embryos
with a transgenically active bir-1 promoter.
Very young adult wild-type hermaphrodite worms were
injected with bir-1 dsRNA to inhibit bir-1 expression as
described above. Worms displaying a 100% penetrant
cytokinesis defect in both gonad arms 15 hours later (as
assessed by the presence of multinucleate embryos in
utero) were re-injected either with an equimolar mixture of
pbir-1GFP and pbir-1Svn or with pbir-1GFP alone. At
36 hours after the injection of pbir-1GFP alone or of 
pbir-1GFP and pbir-1Svn, embryos that had been laid
were collected from the plate and examined.
To determine the extent of cytokinesis (and hence of
rescue), we counted the number of cells present in indi-
vidual embryos. We also assessed GFP fluorescence to
determine which embryos were expressing the injected
transgenes (survivin and GFP under control of the bir-1
promoter). We found that, whereas most embryos
expressing GFP alone failed to cellularise, most embryos
expressing survivin showed a substantial degree of cellu-
larisation (Figure 6). These data suggest that expression
of survivin under the control of the bir-1 promoter can sig-
nificantly suppress the cytokinesis defect resulting from
bir-1 ablation. In no case was the observed partial restora-
tion of cellularisation following survivin expression suffi-
cient to prevent embryonic lethality, however, suggesting
that survivin can only partially substitute for BIR-1 in 
bir-1(RNAi) embryos.
Discussion
In summary, we have identified two C. elegans genes encod-
ing proteins containing regions that have homology to the
BIRs of IAPs. One of these, bir-1, is unable to suppress cell
death following ectopic expression in vivo and inhibition of
bir-1 does not increase cell death in the adult germ line.
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Figure 4
Inhibition of bir-1 by RNAi does not affect cell death in the adult
hermaphrodite germ line. (a) Young adult hermaphrodite worms were
injected with dsRNA corresponding to either bir-1 or ced-9 ORFs and
observed 28 h later. Cell corpses are marked with arrowheads.
Anterior is to the left. (b) The numbers of corpses observed in the
germ lines of young adult hermaphrodite worms were counted 28 h
after injection with dsRNA corresponding to either bir-1 or ced-9
ORFs or with water as a control. Values are means ± standard
deviation for at least 10 animals.
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Inactivation of bir-1 causes a defect in embryonic cytokine-
sis, however, and this can be partially suppressed by trans-
genic expression of survivin, the most closely related
mammalian homologue. We conclude that BIR-1 is not a
general regulator of cell death in C. elegans and that BIRPs
have a conserved role in the regulation of cytokinesis.
Expression of bir-1 and bir-2 has no effect on cell death
We find that overexpression of bir-1 has no significant
effect on developmentally occurring cell death in the
nematode pharynx and that ablation of bir-1 has no effect
on the rate of cell death in the hermaphrodite germ line.
We conclude that BIR-1 is unlikely to act as a general cell
death inhibitor in C. elegans.
This finding clearly does not exclude the possibility that
BIRPs regulate cell death in other organisms: the complete
suppression of reaper-induced cell death in insect cells, both
in vivo [8,11] and in tissue culture [12], by Diap-1 is com-
pelling, and Xiap is a potent inhibitor of certain mammalian
caspases [15,16]. The identification of BIRPs in both fission
and budding yeast [3], however, combined with our demon-
stration that in C. elegans BIRPs do not suppress cell death,
argue that any anti-apoptotic activity of BIRs evolved later
and that BIRs have a more ancient, conserved function.
bir-1 is required for cytokinesis
Inhibition of bir-1 by RNAi causes a defect in the late
stages of cytokinesis. The phenotype of bir-1(RNAi)
embryos is morphologically similar to that following inhi-
bition of either the cyk-1 [35] or the CeMKLP1 C.elegans
genes [36]. The cyk-1 gene encodes a protein with formin
homology (FH) domains that is required for cytokinesis;
FH-domain-containing proteins have an essential role in
Figure 5
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Inhibition of bir-1 by RNAi causes a defect in cytokinesis resulting in a
lack of cellularisation and polyploidy. (a) Comparison of morphology
and DNA localisation in bir-1-ablated embryos. Embryos were removed
from dissected bir-1(RNAi) adult worms and either observed by
Nomarski optics or fixed and stained with DAPI to visualise DNA and
observed by fluorescence microscopy. Embryos are ~50 µm in length.
(b) Time course of development of wild-type and bir-1-ablated
embryos. Embryos were removed from dissected wild-type adult
worms or bir-1(RNAi) adult worms and observed using Nomarski
optics at 20°C. Time is given in min following dissection of the adult.
Initiation of an individual cytokinesis is marked with white arrowheads.
The polar body of a wild-type embryo is marked with a black
arrowhead. Embryos are ~50 µm in length. Anterior is to the left.
cytokinesis in both yeast and Drosophila [37]. CeMKLP1
encodes a microtubule-associated kinesin that is required
for cleavage furrow advancement during cytokinesis.
The morphological similarity between cyk-1(RNAi),
CeMKLP1(RNAi) and bir-1(RNAi) embryos also argues
that the result of bir-1 inhibition is principally a defect 
in cytokinesis.
Cytokinesis uses a complex machinery comprising at least
actin and myosin (reviewed in [38]), the small GTPase
RhoA [39], RhoA effectors such as citron homologues [40]
and IQGAPs [41–44], kinesins [36,45,46], and FH-
domain-containing proteins [35,47]. Although there is no
coherent molecular model of cytokinesis that integrates
the function of such diverse players, one thing is clear: the
requirement that we report here for a BIRP in cytokinesis
is unexpected and, thus far, mechanistically inexplicable.
Analysis of BIR-1 function using the powerful genetics
available in C. elegans should provide insight into how
BIRPs like BIR-1 are involved in cytokinesis, which may
in turn shed light on cytokinesis in general.
Expression of survivin can partially rescue the cytokinesis
defect caused by ablation of bir-1
The finding that transgenic expression of survivin can par-
tially suppress the embryonic cytokinesis defect that arises
following ablation of bir-1 suggests that an involvement in
cytokinesis may be conserved between these two BIRPs.
Structurally, survivin is the BIRP most similar to BIR-1
and the BIR of survivin is very similar to that of BIR-1
(41.4% identity). We have not determined whether the
BIR of survivin is required for survivin’s ability to rescue
the bir-1(RNAi) cytokinesis defect; however, as the only
region with significant homology between BIR-1 and sur-
vivin is in the BIRs, we favour this hypothesis. Survivin is
upregulated ~40-fold at G2–M phase in human cells and
associates with the mitotic spindle via an interaction with
polymerised tubulin. This BIRP is therefore both
expressed at the right time and localised to the correct
place to have a role in cytokinesis.
The structural similarity between BIR-1 and survivin might
suggest that only small BIRPs containing a single BIR are
involved in cytokinesis. There are hints that structurally dif-
ferent BIRPs may also play a similar role in Drosophila,
however. The thread locus encodes Diap-1, a Drosophila
BIRP that has a carboxy-terminal RING finger [8] and is
structurally more similar to the mammalian and viral IAPs
than to survivin and BIR-1. Diap-1 was identified in a
genetic screen for mutations that enhance cell death caused
by ectopic expression of the pro-apoptotic Drosophila gene
reaper [8]. Flies heterozygous for thread loss-of-function
alleles have enhanced levels of reaper-mediated killing, and
ectopic expression of Diap-1 suppresses reaper-induced
killing [8,11,12]. Despite homozygous mutations in the
thread locus in Drosophila being embryonic lethal, however,
the lethality does not appear to be due to an increase in cell
death [8] (as might be predicted if the sole function of Diap-
1 is the suppression of cell death), but instead is due to a
defect in cellularisation [48]. Whether Diap-1, like BIR-1, is
required for cytokinesis in Drosophila is not known, but the
similarity in terminal phenotype is intriguing.
A model for BIRs as regulators of cytoskeleton organisation
The findings that BIR-1 is required for a late event in
cytokinesis, that survivin is functionally homologous to
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Expression of human survivin under the bir-1 promoter can partially
rescue the cytokinesis defect arising from inhibition of bir-1.
(a) Morphology of bir-1(RNAi) embryos following expression of FLAG-
tagged survivin under control of the bir-1 promoter. Adult wild-type
worms in which bir-1 expression had been inhibited by RNAi treatment
were injected either with pbir-1GFP alone or with both pbir-1GFP and
pbir-1Svn (pbir-1GFP + pbir-1Svn) into a single gonad. At 36 h after
injection, embryos that had been laid were examined by both Nomarski
and fluorescence microscopy (GFP). (b) Expression of FLAG-tagged
survivin under the control of the bir-1 promoter partially rescues the
cytokinesis defect in bir-1-ablated embryos. Adult worms displaying a
100% bir-1(RNAi) phenotype were injected either with pbir-1GFP
alone (GFP) or with both pbir-1GFP and pbir-1Svn (survivin). At 36 h
after injection, embryos that had been laid were examined and both the
number of cells and the GFP fluorescence in each embryo determined;
embryos not expressing detectable GFP are designated GFP–.
Results represent the mean ± standard deviation from three
independent experiments. Total number of embryos counted is shown
in parenthesis for each sample.
BIR-1, and that Drosophila embryos with homozygous
loss-of-function mutations in the thread locus are defective
in cellularisation [48], all suggest that BIRs have con-
served functions in worms, flies and mammals. Cytokine-
sis involves major changes in the cytoskeleton, resulting in
profound focal alterations at the plasma membrane and,
ultimately, in the cleavage of a cell into two daughter cells
(for a review, see [38]). One of the main morphological
features of apoptosis is extensive membrane ‘blebbing’
and the release of membrane-enclosed apoptotic bodies
[49]. ‘Pinching-off’ of apoptotic bodies from a dying cell
— a caspase-independent process [50,51] — is reminis-
cent of the cleavage of a cell into two daughter cells
during cytokinesis. On this basis, we suggest that BIRs
mediate interactions with the cytoskeleton and play a role
in various biological processes requiring focal alterations at
the plasma membrane; these may include cytokinesis and
the formation and release of apoptotic bodies. The identi-
fication of proteins that interact with BIRs should provide
further insight into their function.
Materials and methods
Maintenance of C. elegans strains
All strains described were maintained as hermaphrodites at 20°C,
grown on NGMI standard plates and fed with the OP50 bacterial strain
as described [52]. Worms were observed either under a dissecting
microscope (Leica MZ8) or using a Zeiss Axioplan for Nomarski optics.
All injections were performed using standard protocols.
Identification and cloning of bir-1 and bir-2
The bir-1 and bir-2 genes were identified by searching the non-redun-
dant GenBank database with human c-iap1 as a probe with Advanced
Blast. ORFs were cloned by RT–PCR and sequenced.
RNA preparation and northern blot analysis
For RNA purification, wild-type N2 C. elegans were grown in liquid
culture as described [31]. RNA was purified using a standard guani-
dinium-isothiocyanate-based RNA isolation procedure. RNA (10 µg)
from each sample was run on a 0.8% agarose gel containing 1.85%
formamide, 1 µg/ml ethidium bromide. The gel was washed for 45 min
in 20 × SSC, blotted overnight onto Hybond-N+ (Amersham) and the
RNA UV-crosslinked to the membrane using a Stratalinker (Strata-
gene). DNA probes corresponding to either the bir-1 or bir-2 ORFs
were 32P-labelled and used to probe the blots for 18 h at 65°C in
Church buffer. Blots were washed twice in 0.2 × SSC, 0.1% SDS at
65°C and exposed for 36 h to Kodak XAR-5 film at –70°C.
Generation of transgenic worms and expression of genes
under control of heatshock promoters
Sequences encoding either amino-terminally HA-tagged BIR-1
(HA–BIR-1), carboxy-terminally Myc-tagged BIR-1 (BIR-1–Myc) or
untagged BIR-1 were generated by PCR and cloned into vectors
pPD49.78 and pPD49.83, placing them under control of heatshock
promoters [30,53]. To generate transgenic lines, N2 adult worms were
injected in both gonads with 20 ng/µl of each of the DNAs of interest
along with 80 ng/µl pRF4 which contains a dominant rol-6 allele [54].
Transgenes were maintained in these lines as extrachromosomal arrays
[55]. To assay for the effect of heatshock-induced expression of bir-1
or ced-9 (ced-9 strain described in [29]), 30 young rolling transgenic
adult worms were placed on plates and allowed to lay embryos for
45 min. The plates were placed at 30°C in a waterbath for 45 min,
removed to 20°C for 90 min and adult worms removed. Embryos on
the plates subjected to heatshock were allowed to hatch and the pha-
rynges of the resultant L3–L4 transgenic worms were scored 48 h
later. Lysates were prepared from worms 90 min after heatshock, run
on a 12.5% SDS–polyacrylamide gel and blotted onto PVDF mem-
brane (Amersham). Blots were probed with anti-HA antibodies (rabbit
polyclonal; Upstate Biotech) and anti-tubulin antibodies (mouse mono-
clonal DM1A; Sigma) and antibodies detected by enhanced chemilumi-
nescence (Amersham).
RNA synthesis and RNA-mediated inhibition
RNA was synthesised using the Ribomax kit (Promega) and processed
according to manufacturer’s protocols. Sense and antisense strands
were mixed prior to injection to give a final RNA concentration of
1 mg/ml and then annealed. Young adult N2 worms were injected in
both gonads with dsRNA and observed at least 15 h later. Individual
embryos were obtained by dissecting worms in a concave slide and
mouthpipetting released embryos onto a 4% agar pad in M9 buffer and
the embryos observed using a Zeiss Axioplan microscope.
DAPI staining of embryos
Embryos were mouthpipetted onto a slide coated with poly-L-lysine
and glycerine in 4 µl 4% formaldehyde in PBS. A coverslip was placed
over the embryos and the slide flash-frozen in liquid nitrogen. The cov-
erslip was rapidly removed and the slide immersed in acetone at 0°C.
Slides were washed twice in PBS, fixed in 4% formaldehyde in PBS
(5 min, room temperature), washed a further two times in PBS and
10 µl DAPI solution (10 µg/ml in PBS) was overlaid onto the slide.
Rescue of cytokinesis defect caused by bir-1 inhibition by
transgenic expression of human survivin
A region of genomic DNA spanning ~3 kb immediately 5′ to the start
ATG of bir-1 was amplified by PCR using the primers AAACT-
GCAGGGTTCTCGCGGAGCTTGAGCTTGAGCC and AAAGGTAC-
CTTTCTGAAATCAATGAAAAACAACTAGG (oligos from Operon).
We expected that this region would contain not only the bir-1 promoter,
but most of the 5′ sequences that direct endogenous bir-1 expression.
This ~3 kb region was cloned into the PstI–KpnI sites of vector
pPD117.01 to give the vector pbir-1GFP. An ORF encoding human
survivin with an amino-terminal FLAG epitope tag was generated by
PCR and cloned into pbir-1GFP to generate vector pbir-1Svn. Very
young adult wild-type N2 hermaphrodite worms were injected with bir-1
dsRNA to inhibit bir-1. Worms were assessed for the presence of multi-
nucleate embryos in utero 15 h after injection, and worms containing
only mutant embryos in the uterus were reinjected in a single gonad
with either pbir-1GFP alone or with pbir-1GFP and pbir-1Svn. Embryos
were removed from the plate 36 h after injection of the pbir constructs
and examined with both Nomarski and fluorescence microscopy. The
experiment was repeated completely three times and results are the
mean of the three experiments; the error is the standard deviation.
Supplementary material
A figure showing the constructs pbir-1GFP and pbir-1Svn is published
with this paper on the internet.
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S1Supplementary material
Figure S1
Schematic depiction of constructs pbir-1GFP and pbir-1Svn. A ~3 kb
region of genomic DNA immediately 5′ to the start ATG of bir-1 was
cloned into vector pPD117.01, placing it directly upstream of a S65C
variant of GFP that contains three synthetic introns to enhance
expression, to generate construct pbir-1GFP. The GFP-encoding
sequences of pbir-1GFP were excised and replaced by an ORF
encoding an amino-terminally FLAG-epitope-tagged version of survivin
to make construct pbir-1Svn. Exons or coding sequences are depicted
by open boxes, introns are depicted as grey shaded boxes and the
amino-terminal FLAG epitope tag as a black box. The portion of the 3′
UTR of the let-858 gene that provides the polyadenylation site and the
3′ UTR of the message from pbir-1GFP and pbir-1Svn is shown as a
thin open box. The ~3 kb region of the bir-1 promoter is shown as a
thin black box.
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